110 related articles for article (PubMed ID: 29374701)
21. HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.
Liau SS; Jazag A; Whang EE
Cancer Res; 2006 Dec; 66(24):11613-22. PubMed ID: 17178855
[TBL] [Abstract][Full Text] [Related]
22. Association between HMGA1 and immunosuppression in hepatocellular carcinoma: A comprehensive bioinformatics analysis.
Zhu J; Zheng Y; Liu Y; Chen M; Liu Y; Li J
Medicine (Baltimore); 2023 Jan; 102(4):e32707. PubMed ID: 36705364
[TBL] [Abstract][Full Text] [Related]
23. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
Akhter MZ; Sharma A; Rajeswari MR
Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
[TBL] [Abstract][Full Text] [Related]
24. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas.
Masciullo V; Baldassarre G; Pentimalli F; Berlingieri MT; Boccia A; Chiappetta G; Palazzo J; Manfioletti G; Giancotti V; Viglietto G; Scambia G; Fusco A
Carcinogenesis; 2003 Jul; 24(7):1191-8. PubMed ID: 12807722
[TBL] [Abstract][Full Text] [Related]
25. HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma.
Piscuoglio S; Zlobec I; Pallante P; Sepe R; Esposito F; Zimmermann A; Diamantis I; Terracciano L; Fusco A; Karamitopoulou E
Histopathology; 2012 Feb; 60(3):397-404. PubMed ID: 22276603
[TBL] [Abstract][Full Text] [Related]
26. The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors.
De Martino M; Pellecchia S; Esposito F; Tosti N; Quintavalle C; Eppenberger-Castori S; Carafa V; Righi A; Chieffi P; Fusco A; Terracciano LM; Pallante P
Cell Cycle; 2022 Jun; 21(12):1335-1346. PubMed ID: 35282770
[TBL] [Abstract][Full Text] [Related]
27. The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion.
Zhong J; Liu C; Chen YJ; Zhang QH; Yang J; Kang X; Chen SR; Wen GB; Zu XY; Cao RX
J Transl Med; 2016 Mar; 14():80. PubMed ID: 27008379
[TBL] [Abstract][Full Text] [Related]
28. Expression of miR‑26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells.
Sekimoto N; Suzuki A; Suzuki Y; Sugano S
Mol Med Rep; 2017 Feb; 15(2):534-542. PubMed ID: 28000891
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Significance of
Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
[TBL] [Abstract][Full Text] [Related]
30. Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck.
Kadeh H; Saravani S; Heydari F; Shahraki S
Pathol Res Pract; 2016 Oct; 212(10):867-871. PubMed ID: 27567711
[TBL] [Abstract][Full Text] [Related]
31. High-mobility group A1 protein: a new coregulator of peroxisome proliferator-activated receptor-γ-mediated transrepression in the vasculature.
Bloch M; Prock A; Paonessa F; Benz V; Bähr IN; Herbst L; Witt H; Kappert K; Spranger J; Stawowy P; Unger T; Fusco A; Sedding D; Brunetti A; Foryst-Ludwig A; Kintscher U
Circ Res; 2012 Feb; 110(3):394-405. PubMed ID: 22207709
[TBL] [Abstract][Full Text] [Related]
32. The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1.
Massimi I; Guerrieri F; Petroni M; Veschi V; Truffa S; Screpanti I; Frati L; Levrero M; Gulino A; Giannini G
Mol Carcinog; 2013 Jul; 52(7):526-34. PubMed ID: 22389255
[TBL] [Abstract][Full Text] [Related]
33. Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.
Trapasso F; Sarti M; Cesari R; Yendamuri S; Dumon KR; Aqeilan RI; Pentimalli F; Infante L; Alder H; Abe N; Watanabe T; Viglietto G; Croce CM; Fusco A
Cancer Gene Ther; 2004 Sep; 11(9):633-41. PubMed ID: 15272314
[TBL] [Abstract][Full Text] [Related]
34. HMGA1 in cancer: Cancer classification by location.
Wang Y; Hu L; Zheng Y; Guo L
J Cell Mol Med; 2019 Apr; 23(4):2293-2302. PubMed ID: 30614613
[TBL] [Abstract][Full Text] [Related]
35. The high mobility group A1 gene: transforming inflammatory signals into cancer?
Resar LM
Cancer Res; 2010 Jan; 70(2):436-9. PubMed ID: 20068164
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
37. High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade.
Flohr AM; Rogalla P; Bonk U; Puettmann B; Buerger H; Gohla G; Packeisen J; Wosniok W; Loeschke S; Bullerdiek J
Histol Histopathol; 2003 Oct; 18(4):999-1004. PubMed ID: 12973668
[TBL] [Abstract][Full Text] [Related]
38. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
39. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
[TBL] [Abstract][Full Text] [Related]
40. Expression and role of HMGA1 in renal cell carcinoma.
Takaha N; Sowa Y; Takeuchi I; Hongo F; Kawauchi A; Miki T
J Urol; 2012 Jun; 187(6):2215-22. PubMed ID: 22503056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
